WDC

TIDMICON

RNS Number : 2295O

Iconic Labs PLC

30 January 2023

Iconic Labs PLC

("Iconic" or the "Company")

Conversion of Notes and Board Change

Iconic Labs PLC (LSE:ICON), a multi-divisional new media and technology business, announces that it has received two valid Conversion Notices from the European High Growth Opportunities Securitization Fund (" EHGOSF") and a change to the Company's Board of Directors ("Board").

Conversion of Loan Notes

The first Conversion Notice was dated 26 January 2023 and provides for 100 Convertible Notes to be converted into 869,565,217 shares in the Company at a conversion price of GBP0.000115 at the aggregate principal amount of GBP100,000.

The second Conversion Notice was dated 27 January 2023 and provides for 150 Notes to be converted into 1,388,888,888 shares in the Company at a conversion price of GBP 0.000108 at the aggregate principal amount of GBP150,000.

Application is being made for the 2,258,454,105 new ordinary shares to be admitted to trading on the Main Market of the London Stock Exchange which is expected to be on or around 2 February 2023. These shares rank pari passu with the existing ordinary shares of the Company.

Following the issue of these shares, the Company's issued ordinary share capital shall consist of 39,663,702,144 ordinary shares. The figure of 39,663,702,144 represents the total voting rights in the Company and should be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's ("FCA") Disclosure Guidance & Transparency Rules.

Board Change

On 27 January 2023, the Company was informed by Wilhelmus van der Meer that he was stepping down from the Board with immediate effect. The Company is in active discussions with candidates to replace Mr. Van der Meer and an announcement is expected to be made shortly.

Iconic's CEO, Brad Taylor, stated:

" Iconic appreciates Mr. van der Meer's services during the restructuring of the Company and wishes him well in his future business endeavours."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For any further information or enquiries please contact:

ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CONVBLBXXFLBBBX

(END) Dow Jones Newswires

January 30, 2023 03:04 ET (08:04 GMT)

Widecells (LSE:WDC)
Graphique Historique de l'Action
De Mar 2023 à Avr 2023

Widecells (LSE:WDC)
Graphique Historique de l'Action
De Avr 2022 à Avr 2023